IGF2BP1 and gastric adenocarcinoma: The results showed that compared to normal tissues, in STAD patients the expression of HNRNPA2B1, VIRMA, METTL3, WTAPR, HNRNPA2B1, METTL14, BM15, RBM15B, ZC3H13, YTHDC1, YTHDF3, YTHDF1, YTHDF2, HNRNPC, IGF2BP1 IGF2BP2, IGF2BP3, RBMX, FTO, and ALKBH5 was significantly up-regulated (Figure 1A).